journal
MENU ▼
Read by QxMD icon Read
search

Applied Health Economics and Health Policy

journal
https://read.qxmd.com/read/30746616/correction-to-use-of-expert-judgement-across-nice-guidance%C3%A2-making-programmes-a-review-of-current-processes-and-suitability-of-existing-tools-to-support-the-use-of-expert-elicitation
#1
Alison Peel, Michelle Jenks, Moni Choudhury, Rosemary Lovett, Juan Carlos Rejon-Parrilla, Andrew Sims, Joyce Craig
In Sect. 3.3.1, the second sentence of the second paragraph.
February 12, 2019: Applied Health Economics and Health Policy
https://read.qxmd.com/read/30714086/cost-effectiveness-of-dialysis-modalities-a-systematic-review-of-economic-evaluations
#2
REVIEW
Martin Howell, Rachael C Walker, Kirsten Howard
BACKGROUND AND OBJECTIVE: The economic burden of providing maintenance dialysis to those with end-stage kidney disease continues to increase. Home dialysis, including both haemodialysis and peritoneal dialysis, is commonly assumed to be more cost effective than facility dialysis, with some countries adopting a home-first policy in an attempt to reduce costs. However, the cost effectiveness of this approach is uncertain. The aim of this study is to review all published cost-effectiveness analyses comparing all alternative dialysis modalities for people with end-stage kidney disease...
February 4, 2019: Applied Health Economics and Health Policy
https://read.qxmd.com/read/30680700/authors-reply-to-mintz-economic-implications-of-pathogen-reduced-and-bacterially-tested-platelet-components-a-us-hospital-budget-impact-model
#3
LETTER
Laura T Pizzi, Katherine M Prioli, Jay H Herman
No abstract text is available yet for this article.
January 25, 2019: Applied Health Economics and Health Policy
https://read.qxmd.com/read/30680699/comment-on-economic-implications-of-pathogen-reduced-and-bacterially-tested-platelet-components-a-us-hospital-budget-impact-model
#4
LETTER
Paul Mintz
No abstract text is available yet for this article.
January 25, 2019: Applied Health Economics and Health Policy
https://read.qxmd.com/read/30680698/economic-evaluations-of-childhood-hearing-loss-screening-programmes-a-systematic-review-and-critique
#5
REVIEW
Rajan Sharma, Yuanyuan Gu, Theresa Y C Ching, Vivienne Marnane, Bonny Parkinson
BACKGROUND: Permanent childhood hearing loss is one of the most common birth conditions associated with speech and language delay. A hearing screening can result in early detection and intervention for hearing loss. OBJECTIVES: To update and expand previous systematic reviews of economic evaluations of childhood hearing screening strategies, and explore the methodological differences. DATA SOURCES: MEDLINE, Embase, the Cochrane database, National Health Services Economic Evaluation Database (NHS EED), the Health Technology Assessment (HTA) database, and Canadian Agency for Drugs and Technologies in Health's (CADTH) Grey matters...
January 25, 2019: Applied Health Economics and Health Policy
https://read.qxmd.com/read/30675691/vaccination-is-there-a-place-for-penalties-for-non-compliance
#6
Tracey Chantler, Emilie Karafillakis, James Wilson
The introduction of punitive measures to control outbreaks of measles in Europe has sparked debate and public protest about the ethical justification of penalties and exclusionary processes for non-immunisation. This article advances an ethics framework related to compulsory vaccination policies, which we use to analyse three case studies: of mandatory policies that are enforced by fines; of policies that require vaccination for the provision of social goods; and of community-led policies in which communities themselves decide how to enforce vaccination compliance...
January 24, 2019: Applied Health Economics and Health Policy
https://read.qxmd.com/read/30671918/the-value-of-further-research-the-added-value-of-individual-participant-level-data
#7
Pedro Saramago, Manuel A Espinoza, Alex J Sutton, Andrea Manca, Karl Claxton
Judgements based on average cost-effectiveness estimates may disguise significant heterogeneity in net health outcomes. Decisions about coverage of new interventions are often more efficient when they consider between-patient heterogeneity, which is usually operationalized as different selections for different subgroups. While most model-based cost-effectiveness studies are populated with aggregated-level sub-group estimates, individual-level data are recognized as the best source of evidence to produce unbiased and efficient estimates to explore this heterogeneity...
January 23, 2019: Applied Health Economics and Health Policy
https://read.qxmd.com/read/30671917/thopaz-portable-digital-system-for-managing-chest-drains-a-nice-medical-technology-guidance
#8
REVIEW
James Michael Evans, Alistair Ray, Megan Dale, Helen Morgan, Paul Dimmock, Grace Carolan-Rees
The Thopaz+ portable digital system was evaluated by the Medical Technologies Advisory Committee (MTAC) of the National Institute for Health and Care Excellence (NICE). The manufacturer, Medela, submitted a case for the adoption of Thopaz+ that was critiqued by Cedar, on behalf of NICE. Due to a lack of clinical evidence submitted by the manufacturer, Cedar carried out its own literature search. Clinical evidence showed that the use of Thopaz+ led to shorter drainage times, a shorter hospital stay, lower rates of chest drain re-insertion and higher patient satisfaction compared to conventional chest drainage when used in patients following pulmonary resection...
January 23, 2019: Applied Health Economics and Health Policy
https://read.qxmd.com/read/30635844/recell-%C3%A2-spray-on-skin-system-for-treating-skin-loss-scarring-and-depigmentation-after-burn-injury-a-nice-medical-technology-guidance
#9
REVIEW
Susan Caroline Peirce, Grace Carolan-Rees
The gold standard treatment for deep burns is an autologous skin graft; in larger burns this may be meshed to increase the area covered. However, long-term aesthetic and functional outcomes of graft scars may be poor. ReCell® is a medical device that processes skin samples in the operating theatre into a cell suspension to be sprayed or dripped onto a wound. It is claimed to improve healing and scar appearance. This device was evaluated by the National Institute for Health and Care Excellence (NICE) Medical Technologies Evaluation Programme...
January 11, 2019: Applied Health Economics and Health Policy
https://read.qxmd.com/read/30617458/real-world-cost-effectiveness-of-mandatory-folic-acid-fortification-of-bread-making-flour-in-australia
#10
Sopany Saing, Phil Haywood, Naomi van der Linden, Kathleen Manipis, Elena Meshcheriakova, Stephen Goodall
BACKGROUND: In 2009, mandatory folic acid fortification of bread-making flour was introduced in Australia to reduce the birth prevalence of preventable neural tube defects (NTDs) such as spina bifida. Before the introduction of the policy, modelling predicted a reduction of 14-49 NTDs each year. OBJECTIVE: Using real-world data, this study provides the first ex-post evaluation of the cost effectiveness of mandatory folic acid fortification of bread-making flour in Australia...
January 8, 2019: Applied Health Economics and Health Policy
https://read.qxmd.com/read/30599049/the-association-between-adiposity-and-inpatient-hospital-costs-in-the-uk-biobank-cohort
#11
Padraig Dixon, George Davey Smith, William Hollingworth
BACKGROUND: High adiposity is associated with higher risks for a variety of adverse health outcomes, including higher rates of age-adjusted mortality and increased morbidity. This has important implications for the management of healthcare systems, since the endocrinal, cardiometabolic and other changes associated with increased adiposity may be associated with substantial healthcare costs. METHODS: We studied the association between various measures of adiposity and inpatient hospital costs through record linkage between UK Biobank and records of inpatient care in England and Wales...
December 31, 2018: Applied Health Economics and Health Policy
https://read.qxmd.com/read/30535675/modelled-economic-evaluation-of-nivolumab-for-the-treatment-of-second-line-advanced-or-metastatic-squamous-non-small-cell-lung-cancer-in-australia-using-both-partition-survival-and-markov-models
#12
Lan Gao, Shu-Chuen Li
OBJECTIVES: To assess the cost-effectiveness of nivolumab for patients with advanced or metastatic squamous non-small-cell lung cancer (NSCLC) progressed on or after platinum-based chemotherapy using a modelled economic evaluation. METHODS: Both partition survival (PS) and Markov models, comprised of three health states, were adopted to evaluate the cost-effectiveness of nivolumab compared to docetaxel from an Australian healthcare system perspective with a 6-year time horizon...
December 10, 2018: Applied Health Economics and Health Policy
https://read.qxmd.com/read/30520000/reducing-drug-wastage-in-pharmaceuticals-dosed-by-weight-or-body-surface-areas-by-optimising-vial-sizes
#13
Anthony J Hatswell, Joshua K Porter
BACKGROUND: When pharmaceuticals are administered based on patient characteristics (for example weight or body surface area), an amount of product will be unused and must be disposed of. This wastage represents inefficiency and can distort decision making. METHODS: We present a method for the analysis of optimum fill volumes of pharmaceuticals to minimise wastage across a patient population, using publicly available data. Wastage for patients at each 'step' e.g...
December 5, 2018: Applied Health Economics and Health Policy
https://read.qxmd.com/read/30506456/a-payer-perspective-of-the-hospital-inpatient-additional-care-costs-of-antimicrobial-resistance-in-france-a-matched-case-control-study
#14
Mehdi Touat, Marion Opatowski, Christian Brun-Buisson, Kristel Cosker, Didier Guillemot, Jerome Salomon, Philippe Tuppin, Gregoire de Lagasnerie, Laurence Watier
BACKGROUND AND OBJECTIVE: Antimicrobial resistance (AMR) has become one of the biggest threats to global public health given its association with mortality, morbidity and cost of health care. However, little is known on the economic burden of hospitalization attributable to AMR from a public health insurance perspective. We assessed the excess costs to the French public health insurance system attributable to AMR infections in hospitals. METHODS: Bacterial infectious disease-related hospitalizations were extracted from the National health data information system for all stays occurring in 2015...
December 3, 2018: Applied Health Economics and Health Policy
https://read.qxmd.com/read/30484140/financial-impact-of-alternative-pricing-benchmarks-for-physician-dispensed-drugs-in-the-california-workers-compensation-system
#15
Leslie Wilson, Fatema Turkistani, Dang M Tran, Wei Huang, Tracy Kuo Lin
BACKGROUND: Pricing drugs in the California Workers' Compensation System (CAWCS) has become more difficult as there are increasingly fewer drugs listed in the Medi-Cal primary fee schedule, which is used as the source for CAWCS drug prices. This presents a challenge of providing timely and accurate CAWCS reimbursement. The objectives of this study are (1) to explore any trends in physician-dispensed drug prices; (2) to compare the proportion of drugs with and without a price and to determine the financial implications of repricing CAWCS physician-dispensed drugs with five alternative pricing benchmarks; and (3) to offer recommendations for the pricing benchmark to maximize pricing coverage and to remain budget neutral...
November 28, 2018: Applied Health Economics and Health Policy
https://read.qxmd.com/read/30073485/use-of-expert-judgement-across-nice-guidance-making-programmes-a-review-of-current-processes-and-suitability-of-existing-tools-to-support-the-use-of-expert-elicitation
#16
Alison Peel, Michelle Jenks, Moni Choudhury, Rosemary Lovett, Juan Carlos Rejon-Parrilla, Andrew Sims, Joyce Craig
OBJECTIVES: This study aimed to review current use of experts within National Institute for Health and Care Excellence (NICE) guidance-making programmes, identify improvements in use of expert judgement, and to assess tools and protocols to support the elicitation of information from experts for use by NICE. METHODS: The study comprised a review of NICE process guides; semi-structured interviews with individuals representing each NICE guidance-making programme and a comparison of the suitability of currently available tools and protocols for expert elicitation to the requirements of NICE programmes...
December 2018: Applied Health Economics and Health Policy
https://read.qxmd.com/read/30467732/comment-on-does-mcda-trump-cea
#17
LETTER
Aris Angelis, Panos Kanavos
No abstract text is available yet for this article.
November 21, 2018: Applied Health Economics and Health Policy
https://read.qxmd.com/read/30465319/cost-effectiveness-of-new-diagnostic-tools-for-cutaneous-leishmaniasis-in-afghanistan
#18
Céline Aerts, Martijn Vink, Sayed Jalal Pashtoon, Sami Nahzat, Albert Picado, Israel Cruz, Elisa Sicuri
BACKGROUND AND OBJECTIVES: Cutaneous leishmaniasis is responsible for chronic and disfiguring skin lesions resulting in morbidity and social stigma. The gold standard to diagnose cutaneous leishmaniasis is microscopy but has a variable sensitivity and requires trained personnel. Using four scenarios, the objective of this study is to compare the cost effectiveness of microscopy with two new tools: Loopamp™ Leishmania Detection Kit (LAMP) and CL Detect™ Rapid Test (RDT). METHODS: Data related to the cost and accuracy of these tools were collected at the clinic of the National Malaria and Leishmaniasis Control Program in Kabul, Afghanistan...
November 21, 2018: Applied Health Economics and Health Policy
https://read.qxmd.com/read/30460622/authors-reply-to-angelis-and-kanavos-does-mcda-trump-cea
#19
LETTER
Carlos Campillo-Artero, Jaume Puig-Junoy, Anthony J Culyer
No abstract text is available yet for this article.
November 21, 2018: Applied Health Economics and Health Policy
https://read.qxmd.com/read/30426450/peristeen-transanal-irrigation-system-to-manage-bowel-dysfunction-a-nice-medical-technology-guidance
#20
REVIEW
Megan Dale, Helen Morgan, Kimberly Carter, Judith White, Grace Carolan-Rees
The Peristeen transanal irrigation system is intended to allow people with bowel dysfunction to flush out the lower part of the bowel as part of their bowel management strategy. Peristeen was the subject of an evaluation by the National Institute for Health and Care Excellence, through its Medical Technologies Evaluation Programme, for the management of bowel dysfunction. The company, Coloplast, submitted a case for adoption of the technology, claiming that the technology improves the severity of chronic constipation or faecal incontinence and improves quality of life for people with bowel dysfunction...
November 14, 2018: Applied Health Economics and Health Policy
journal
journal
40237
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"